|
|
The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.
In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.
Women are 50% to 75% more likely than men to experience an adverse drug reaction.
Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%
The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.